New York Assembly Bill A01248

New York 2025-2026 Regular Session

• Introduced: 1/9/25
• Refer: 1/9/25
• Report Pass: 3/25/25
• Refer: 3/25/25
• Report Pass: 4/2/25
• Refer: 4/2/25
• Report Pass: 5/20/25
• Refer: 5/20/25
• Report Pass: 5/21/25
• Engrossed: 5/21/25
• Refer: 5/21/25
• Engrossed: 5/27/25
• Engrossed: 3/10/26
• Refer: 3/10/26

Caption

Prohibits the knowing sale, offer for sale, or delivery of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Impact

If enacted, A01248 will amend the existing General Business Law by ensuring stricter control over the distribution of xylazine within the state. By enforcing age restrictions and requiring proof of necessary usage, the legislation seeks to close loopholes that may allow for exploitation of this drug. The overall goal is to enhance public safety and address the growing health concerns related to the unregulated sale of pharmaceutical substances that can be harmful when misused.

Summary

Bill A01248 aims to regulate the sale of xylazine, a pharmaceutical drug primarily used for sedation and anesthesia in animals. The bill specifically prohibits the sale of xylazine in quantities of fifty grams or more to individuals under the age of 21 and requires that sellers obtain proof of intended use for institutional, veterinary, or scientific purposes. This measure is introduced to mitigate the potential misuse and adverse effects of xylazine in humans, especially in light of recent concerns regarding its increasing prevalence in illegal drug mixtures.

Contention

While the bill has garnered support for its proactive approach to controlling potentially dangerous substances, some stakeholders may view the regulations as overly stringent. Concerns have been voiced regarding the implications for legitimate veterinary practices, where access to xylazine is needed for appropriate animal care. The debate centers around finding the right balance between safeguarding public health and ensuring that veterinary professionals have the necessary resources to treat their patients effectively.